A new ganglion blocking agent: trial of Ciba 9295 in man.

A new ganglion blocking agent: trial of Ciba 9295 in man. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A new ganglion blocking agent: trial of Ciba 9295 in man. Abstract Text:

A G BAIKIE,J R SMITH,

A new ganglion blocking agent: trial of Ciba 9295 in man. Publishing Authors By Initials

AG BAIKIE,JR SMITH,

For similar cardiovascular system research abstracts see: cardiovascular system research

PUBMED ID PMID:

MEDLINE DATE:

A new ganglion blocking agent: trial of Ciba 9295 in man. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Lancet

VOLUME: 1

Page Numbers: 1144-5

Journal Abbreviation: Lancet

ISSN: 0140-6736

DAY: 7

MONTH: Jun

YEAR: 1952

A new ganglion blocking agent: trial of Ciba 9295 in man. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985213

A new ganglion blocking agent: trial of Ciba 9295 in man. Keywords Mesh Terms:

KEYWORDS: Cardiovascular System

MESH TERMS: drug effects

Chemical & Substance for Abstract: A new ganglion blocking agent: trial of Ciba 9295 in man. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A new ganglion blocking agent: trial of Ciba 9295 in man.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Lancet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A new ganglion blocking agent: trial of Ciba 9295 in man Related Publications

• 10 do's and don'ts about tax homes.
• A gravitational lens.
• An animal evaluation of a paste of chitosan glutamate and hydroxyapatite as a synthetic bone graft material.
• An electrostrictive drive for fine pitch control in double-crystal monochromators.
• Animal model of human disease: inherited erythrocyte glutathione deficiency.
• Bacterial pathogens of the respiratory tract of the newborn infant.
• Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin.
• Calculating Society's Willingness to Pay for a QALY : Key Questions for Discussion.
• Characterizing the structures and folding of free proteins using 2-D gas-phase separations: observation of multiple unfolded conformers.
• Coccidioidomycosis.
• Demoralization, anhedonia and grief in patients with severe physical illness.
• Developmental outcomes after early or delayed insertion of tympanostomy tubes.
• Effects of hormone-induced superovulation on latent infectious bovine rhinotracheitis virus in cattle.
• Euphemistic codes and tell-tale hearts: humane assistance in end-of-life cases.
• Evaluation of beta-endorphin and naloxone on bovine uterine motility.
• Gastrointestinal disease in adolescents.
• Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet.
• Joys of teaching nursing.
• Occupational health in India.
• Odontoblast morphology and dental repair.
• Practical management of tuberculosis.
• Preventing and treating: Heart disease in women.
• Synthesis of 4,4-difluoroglycosides using ring-closing metathesis.
• The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus.
• The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro.
• The effects of xylazine hydrochloride on intrauterine pressure in the cow.
• The reliability of willingness to pay for changes in health status.
• The role of primary care in infertility management.
• What is happening in the real world in lipid therapy and is it appropriate? The need for a paradigm shift.
• X-ray Imaging and Microspectroscopy of Plants and Fungi.